ATE214070T1 - Galanthaminderivate und verfahren zu deren herstellung - Google Patents

Galanthaminderivate und verfahren zu deren herstellung

Info

Publication number
ATE214070T1
ATE214070T1 AT96931169T AT96931169T ATE214070T1 AT E214070 T1 ATE214070 T1 AT E214070T1 AT 96931169 T AT96931169 T AT 96931169T AT 96931169 T AT96931169 T AT 96931169T AT E214070 T1 ATE214070 T1 AT E214070T1
Authority
AT
Austria
Prior art keywords
pct
hydrogen
alkaryl
sec
aryl
Prior art date
Application number
AT96931169T
Other languages
English (en)
Inventor
Peter David Tiffin
Neil Fraser
David Andrew Chaplin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE214070T1 publication Critical patent/ATE214070T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96931169T 1995-09-21 1996-09-23 Galanthaminderivate und verfahren zu deren herstellung ATE214070T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9519267.0A GB9519267D0 (en) 1995-09-21 1995-09-21 Preparation of alkaloids
PCT/GB1996/002334 WO1997011077A1 (en) 1995-09-21 1996-09-23 Galanthamine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ATE214070T1 true ATE214070T1 (de) 2002-03-15

Family

ID=10781038

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931169T ATE214070T1 (de) 1995-09-21 1996-09-23 Galanthaminderivate und verfahren zu deren herstellung

Country Status (13)

Country Link
US (1) US6093815A (de)
EP (1) EP0854873B1 (de)
AT (1) ATE214070T1 (de)
AU (1) AU714711B2 (de)
CA (1) CA2230826C (de)
CY (1) CY2301B1 (de)
DE (1) DE69619685T2 (de)
DK (1) DK0854873T3 (de)
ES (1) ES2173316T3 (de)
GB (1) GB9519267D0 (de)
PT (1) PT854873E (de)
WO (1) WO1997011077A1 (de)
ZA (1) ZA968028B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891954A3 (de) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Wirkstoffe zur Verbesserung der Exkretionskraft der Harnblase
JP2003136077A (ja) * 2001-10-31 2003-05-13 Nec Corp 半導体製造に用いる洗浄水又は浸漬水の製造装置
US20050142193A1 (en) * 2003-12-31 2005-06-30 Lijuan Tang Galantamine formulations
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine
DE602006016441D1 (de) * 2005-05-13 2010-10-07 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
AT504663B1 (de) * 2007-02-22 2008-07-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- f)(2) benzazepinen sowie dessen derivaten
EP2009015B1 (de) * 2007-06-18 2012-01-11 Aurobindo Pharma Limited Herstellungsprozess für Galantaminhydrobromid
AT507039A1 (de) 2008-06-26 2010-01-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen benzazepinderivaten
CN106977412B (zh) * 2017-05-15 2019-08-02 张家港威胜生物医药有限公司 一种加兰他敏关键中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100195399B1 (ko) * 1987-05-04 1999-06-15 보니데이비스 알쯔하이머 병 치료용 의약
PL184590B1 (pl) * 1994-10-21 2002-11-29 Sanochemia Pharmazeutika Ag Sposób wytwarzania pochodnych a heksahydro H benzofuro[ a ef][ ] benzoazepiny sposób odbromowania tych pochodnych sposób wytwarzania związków typu N demetylobromo i epibromo galantaminy oraz nowe związki z określonego zbioru
AT401058B (de) * 1994-10-21 1996-06-25 Waldheim Pharmazeutika Gmbh Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins

Also Published As

Publication number Publication date
AU714711B2 (en) 2000-01-06
US6093815A (en) 2000-07-25
AU6996496A (en) 1997-04-09
GB9519267D0 (en) 1995-11-22
DK0854873T3 (da) 2002-07-01
EP0854873B1 (de) 2002-03-06
DE69619685T2 (de) 2002-10-17
WO1997011077A1 (en) 1997-03-27
CA2230826C (en) 2008-09-02
PT854873E (pt) 2002-08-30
ES2173316T3 (es) 2002-10-16
CY2301B1 (en) 2003-07-04
EP0854873A1 (de) 1998-07-29
CA2230826A1 (en) 1997-03-27
ZA968028B (en) 1997-09-23
DE69619685D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69419505D1 (de) Verfahren zur herstellung von zwischenprodukten zur synthese von antimykotika
BR9612216A (pt) Processo para preparar um composto derivado de piperidina, regioisómero, processo para preparar um regioisómero, derivado de alfa, alfa- di-substituído, e alfa,alfa-di não substituído metilbenzeno, derivado de oxobutila, precursor de derivado de piperidina e processo para tratar reações alérgicas em um paciente.
ATE214070T1 (de) Galanthaminderivate und verfahren zu deren herstellung
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
DE69214784D1 (de) Verfahren zur herstellung von cephalosporinzwischenverbindungen
AP1519A (en) Process for the preparation of thiazolidinedione derivatives.
DE69728180D1 (de) Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten
ATE301659T1 (de) Verfahren zur herstellung von campothecinderivate
DE69616719D1 (de) Verfahren zur herstellung von taxol und seiner derivate
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
BG101501A (en) Nitro-benzamides useful as anti-arrhytmic agents
ATE131169T1 (de) 2-pyranon-derivat und verfahren zu dessen herstellung.
SE8207194L (sv) Estrar av 4-hydroximetyl-1-ftalazonderivat och salter derav
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE59508739D1 (de) Verfahren zur herstellung von 2-piperazincarbonsäurederivaten
ATE217316T1 (de) Verfahren zur herstellung von diphosphonat- derivaten
ATE142637T1 (de) Neues verfahren zur herstellung von 20-oxo, 17- alpha, 21-dihydroxy derivaten von pregnan und neue zwischenprodukte dafür
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
IL125873A (en) 1(2h) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properites
DE3567205D1 (en) Method for the preparation of amino-triazinone derivatives
SE8302886D0 (sv) Intermediates for preparing substituted 1-piperazine-carboxamides and carbothioamides and use thereof
DE59804539D1 (de) 15-methyl-cyclopropanosteroide und verfharen zu ihrer herstellung
ATE378319T1 (de) Verfahren zur herstellung von imidazolonen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification